InvestorsHub Logo
Followers 5
Posts 207
Boards Moderated 0
Alias Born 02/14/2021

Re: None

Sunday, 10/02/2022 5:22:16 PM

Sunday, October 02, 2022 5:22:16 PM

Post# of 459309
So let’s assume AD results don’t show statistically significant and clinically meaningful changes. I believe blarcamesine will nonetheless be approved for Rett. I don’t need the money right now and the tax bill if I sold at current price would be tens of thousands closer to six figures…

Why sell even with run up to $20?

In three to five, this will be at least $20 with Rett approval and concomitant revenues. Anyone else in my boat and using similar strategy?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News